FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma

10Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Myxoid liposarcoma is one of the most common sarcoma entities characterized by FET fusion oncogenes. Despite a generally favorable prognosis of myxoid liposarcoma, chemotherapy resistance remains a clinical problem. This cancer stem cell property is associated with JAK-STAT signaling, but the link to the myxoid-liposarcoma-specific FET fusion oncogene FUS-DDIT3 is not known. Here, we show that ectopic expression of FUS-DDIT3 resulted in elevated levels of STAT3 and phosphorylated STAT3. RNA sequencing identified 126 genes that were regulated by both FUS-DDIT3 expression and JAK1/2 inhibition using ruxolitinib. Sixty-six of these genes were connected in a protein interaction network. Fifty-three and 29 of these genes were confirmed as FUS-DDIT3 and STAT3 targets, respectively, using public chromatin immunoprecipitation sequencing data sets. Enriched gene sets among the 126 regulated genes included processes related to cytokine signaling, adipocytokine signaling, and chromatin remodeling. We validated CD44 as a target gene of JAK1/2 inhibition and as a potential cancer stem cell marker in myxoid liposarcoma. Finally, we showed that FUS-DDIT3 interacted with phosphorylated STAT3 in association with subunits of the SWI/SNF chromatin remodeling complex and PRC2 repressive complex. Our data show that the function of FUS-DDIT3 is closely connected to JAK-STAT signaling. Detailed deciphering of molecular mechanisms behind tumor progression opens up new avenues for targeted therapies in sarcomas and leukemia characterized by FET fusion oncogenes.

References Powered by Scopus

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

54481Citations
N/AReaders
Get full text

NIH Image to ImageJ: 25 years of image analysis

47068Citations
N/AReaders
Get full text

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

35977Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Myxoid Liposarcomas: Systemic Treatment Options

12Citations
N/AReaders
Get full text

Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic Fusion Proteins: Current Status and Clinical

7Citations
N/AReaders
Get full text

Rapid and reversible dissolution of biomolecular condensates using light-controlled recruitment of a solubility tag

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Dolatabadi, S., Jonasson, E., Andersson, L., Luna Santamaría, M., Lindén, M., Österlund, T., … Ståhlberg, A. (2022). FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.816894

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Lecturer / Post doc 1

33%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 3

43%

Medicine and Dentistry 2

29%

Engineering 1

14%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Save time finding and organizing research with Mendeley

Sign up for free